Get the Daily Brief
Latest Biotech News
FDA Approves Merck’s RSV Antibody For Infant Use Amid Advisory Shakeup
The FDA granted approval to Merck's monoclonal antibody drug Enflonsia for preventing respiratory syncytial virus (RSV) infections in infants under 12 months. The drug is priced competitively...
Metsera’s Long-Acting Amylin Analog Shows Promising Obesity Trial Results
Metsera reported encouraging phase I data for its long-acting amylin analogue MET-233i, indicating dose-dependent weight loss efficacy and potential for once-monthly dosing. The therapy exhibited...
Merck's Oral PCSK9 Inhibitor Advances With Dual Phase III Success
Merck announced successful outcomes from two phase III studies evaluating its oral PCSK9 inhibitor, enlicitide decanoate, in patients with high cholesterol on statin therapy. The drug demonstrated...
Recursion Cuts 20% of Staff Following Pipeline Restructuring
Recursion Pharmaceuticals disclosed a 20% reduction in workforce following a recent decision to narrow its research focus and deprioritize multiple clinical-stage programs. This downsizing...
Merck’s RSV Antibody Enters Market While CDC Vaccine Advisory Panel Is Reconstituted
Merck received FDA approval for its RSV antibody drug, Enflonsia, targeting infants under 12 months and directly competing with Sanofi and AstraZeneca’s Beyfortus. The approval occurs amid a...
Biotech Industry Financial and Corporate Movements
Biotech firms navigate financial turbulence and strategic deals amid sector-wide shifts. Recursion Pharmaceuticals announced 20% workforce layoffs linked to clinical pipeline cuts after merging...
Novel Technologies in Diagnostics and Therapeutics
Innovations span diagnostics and treatment modalities, including AI-powered rapid viral detection via nanopore technology, promising faster clinical decisions. Linear Diagnostics secured £1M UK...
Emerging Regulatory and NIH Funding Challenges in Biotech Research
The biotech community faces mounting challenges from politicization and funding cuts. Researchers issued the Bethesda Declaration urging restoration of NIH grants delayed or terminated under the...
Alzheimer’s and Neurodegenerative Disease Advances
Multiple studies illuminate neurodegenerative disease mechanisms and diagnosis. Dr. Sophia Shi detailed how sugar molecule degradation in the brain’s glycocalyx contributes to aging and...
Innovations in Bioprinting and Tissue Engineering Materials
Researchers at Stony Brook University developed TRACE (Tunable Rapid Assembly of Collagenous Elements), a novel collagen bioprinting method enabling instant assembly of physiological collagen...
Breakthroughs in Cancer Diagnostics and Therapeutics
Recent studies advance cancer care with novel diagnostic and therapeutic approaches. Indiana University secured FDA clearance for the first blood test detecting Alzheimer’s amyloid pathology,...
AI Advances Enhance Drug Discovery and Genetic Insights
Biotech and academic researchers harness artificial intelligence to unravel genetic networks and streamline drug discovery. Northwestern University developed TWAVE, an AI tool identifying gene...
Metsera's Amylin Analogue Shows Promise for Obesity Treatment
Metsera Inc. released early clinical data indicating their long-acting amylin analogue, MET-233i, induces significant dose-dependent weight loss with an extended half-life supporting once-monthly...
Oral PCSK9 Inhibitors Demonstrate Efficacy in Late-Stage Trials
Merck & Co. reported positive results from two Phase III trials of their oral PCSK9 inhibitor enlicitide decanoate, achieving statistically significant reductions in LDL cholesterol in patients...
FDA Approves Competing RSV Antibody Drugs Amid Advisory Committee Overhaul
Merck's RSV antibody drug Enflonsia has received FDA approval for infants under 12 months, entering a market dominated by Sanofi and AstraZeneca's Beyfortus. This approval coincides with the...